Drexel University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Philadelphia PA United States (1891)

Organization Overview

First Clinical Trial
1985
NCT00589706
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Division of Infectious Diseases and HIV Medicine, Drexel University College of Medicine | Drexel | Drexel College of Medicine | Drexel Coulter Translational Research Partnership Program | Drexel University | Drexel University Center for Weight, Eating and Lifestyle Science | Drexel University College of Medicine | The Center for Pediatric Pharmacotherapy

Active Ingredients

Drugs in Phase 4 Trials (7)

etomidate (amidate) (1 trial)

fentanyl (Innovar) (1 trial)

ketamine (ketalar) (2 trials)

levetiracetam (keppra) (1 trial)

lidocaine (xylocaine) (2 trials)

midazolam (versed) (1 trial)

mycophenolate (CellCept) (1 trial)

Drugs in Phase 3 Trials (6)

basiliximab (Simulect) (1 trial)

hydroxyurea (hydrea) (1 trial)

lithium (lithonate) (1 trial)

methylnaltrexone (relistor) (1 trial)

olanzapine (zyprexa) (2 trials)

sodium chloride (2 trials)

Drugs in Phase 2 Trials (27)

99mtc-glucarate (1 trial)

ags-004 (1 trial)

aripiprazole (abilify) (1 trial)

autologous hematopoietic stem cells (1 trial)

busulfan (Myleran) (1 trial)

calcium glycerylphosphate (1 trial)

cetuximab (erbitux) (1 trial)

chloroquine (1 trial)

cisplatin (platinol) (1 trial)

cytarabine (cytosar-u) (1 trial)

docetaxel (taxotere) (1 trial)

epoetin (Epogen) (1 trial)

etoposide (vepesid) (1 trial)

fludarabine (fludara) (1 trial)

fluorouracil (efudex) (1 trial)

icosapent ethyl (vascepa) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

isotretinoin (Accutane) (1 trial)

leucovorin (1 trial)

mab-425 (2 trials)

palifermin (Kepivance) (1 trial)

pro-140 monoclonal antibody (2 trials)

sargramostim (leukine) (2 trials)

sirolimus (rapamune) (1 trial)

topotecan (hycamtin) (1 trial)

vitamin e (1 trial)

ziprasidone (geodon) (1 trial)

Drugs in Phase 1 Trials (8)

bone marrow derived mesenchymal stem cells (1 trial)

cefazolin (ancef) (1 trial)

genevax il-12-4532 (1 trial)

interleukin-12 (1 trial)

interleukin-15 (1 trial)

pennvax-b (1 trial)

profectus hiv mag pdna vaccine (1 trial)

vancomycin (Vancocin) (1 trial)

Drugs in Other Trials (7)

aprepitant (Emend) (3 trials)

magnesium oxide (1 trial)

morphine (1 trial)

rifampin (1 trial)

scopolamine (transderm scop) (2 trials)

urea (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 2)

Acute Coronary Syndrome (Phase 2)

Aggression (Phase 3)

Anemia (Phase 3)

Anemia, Sickle Cell (Phase 3)

Atrophy (Phase 2)

Autistic Disorder (Phase 3)

Chest Pain (Phase 2)

Communicable Diseases (Phase 2)

Complex Regional Pain Syndromes (Phase 2)

Conduct Disorder (Phase 3)

Disease (Phase 3)

Epilepsy (Phase 4)

Glioma (Phase 2)

Head and Neck Neoplasms (Phase 2)

Hematologic Diseases (Phase 3)

HIV Infections (Phase 2)

Infections (Phase 2)

Inflammation (Phase 2)

Kidney Failure, Chronic (Phase 3)

Leukemia (Phase 2)

Liver Diseases (Phase 4)

Myelodysplastic Syndromes (Phase 2)

Myeloproliferative Disorders (Phase 2)

Osteochondrodysplasias (Phase 1)

Preleukemia (Phase 2)

Reflex Sympathetic Dystrophy (Phase 2)

Renal Insufficiency (Phase 1)

Sickle Cell Trait (Phase 2)

Syndrome (Phase 2)

Thalassemia (Phase 2)

Thrombocytopenia (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 38
  • # of Trial APIs: 55